20/20 GeneSystems is the #2 leader in the U.S. is the fast-growing market for multi-cancer early detection(MCED)blood tests.
An innovative oncology-focused startup company, led by proven drug hunter, that is poised to transform the lives of cancer patients with high unmet needs.